1. Home
  2. ADMA vs FBP Comparison

ADMA vs FBP Comparison

Compare ADMA & FBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • FBP
  • Stock Information
  • Founded
  • ADMA 2004
  • FBP 1948
  • Country
  • ADMA United States
  • FBP United States
  • Employees
  • ADMA N/A
  • FBP N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • FBP Major Banks
  • Sector
  • ADMA Health Care
  • FBP Finance
  • Exchange
  • ADMA Nasdaq
  • FBP Nasdaq
  • Market Cap
  • ADMA 4.1B
  • FBP 3.3B
  • IPO Year
  • ADMA N/A
  • FBP N/A
  • Fundamental
  • Price
  • ADMA $17.91
  • FBP $17.64
  • Analyst Decision
  • ADMA Strong Buy
  • FBP Buy
  • Analyst Count
  • ADMA 4
  • FBP 4
  • Target Price
  • ADMA $22.50
  • FBP $22.00
  • AVG Volume (30 Days)
  • ADMA 2.7M
  • FBP 1.0M
  • Earning Date
  • ADMA 03-03-2025
  • FBP 04-22-2025
  • Dividend Yield
  • ADMA N/A
  • FBP 4.10%
  • EPS Growth
  • ADMA N/A
  • FBP 5.85
  • EPS
  • ADMA 0.81
  • FBP 1.81
  • Revenue
  • ADMA $426,454,000.00
  • FBP $879,847,000.00
  • Revenue This Year
  • ADMA $16.18
  • FBP $3.09
  • Revenue Next Year
  • ADMA $23.92
  • FBP $6.97
  • P/E Ratio
  • ADMA $22.12
  • FBP $9.75
  • Revenue Growth
  • ADMA 65.15
  • FBP 1.92
  • 52 Week Low
  • ADMA $5.88
  • FBP $16.24
  • 52 Week High
  • ADMA $23.64
  • FBP $22.40
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 58.84
  • FBP 28.11
  • Support Level
  • ADMA $15.88
  • FBP $17.26
  • Resistance Level
  • ADMA $18.25
  • FBP $18.66
  • Average True Range (ATR)
  • ADMA 1.12
  • FBP 0.48
  • MACD
  • ADMA 0.25
  • FBP -0.20
  • Stochastic Oscillator
  • ADMA 86.13
  • FBP 13.64

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About FBP First BanCorp. New

First BanCorp is a financial holding company. The company's operating segment includes Commercial and Corporate Banking; Mortgage Banking; Consumer (Retail) Banking; Treasury and Investments; United States Operations; and Virgin Islands Operations. It generates maximum revenue from the Consumer (Retail) Banking segment. The Consumer (Retail) Banking segment generates majority revenue, which consists of the Corporation's consumer lending and deposit-taking activities conducted mainly through its branch network and loan centres. Geographically, it derives a majority of revenue from Puerto Rico.

Share on Social Networks: